---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-067790"
form_type: "8-K"
ticker: "ORKA"
cik: "0000907654"
company_name: "Oruka Therapeutics, Inc."
filed_at: "2023-12-04T23:59:59+00:00"
generated_at: "2026-06-07T19:06:50.343871+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ARCA biopharma increases retention bonuses for two execs by 50% to $150,000 each

## Summary
- Retention bonus for Thomas Keuer and C. Jeffrey Dekker increased 50% to $150,000 each.
- Early payment of $35,000 on Dec 8, 2023, to assist with tax obligations on RSU vesting.
- Remaining $115,000 payable upon corporate transaction or board approval of clinical decisions.
- Eligibility requires continued employment in good standing through payment event dates.

## SEC filing metadata
- accession: 0000950170-23-067790
- form_type: 8-K
- ticker: ORKA
- cik: 0000907654
- company_name: Oruka Therapeutics, Inc.
- filed_at: 2023-12-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/907654/000095017023067790/0000950170-23-067790-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/907654/000095017023067790/abio-20231129.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-067790
- JSON: https://secwatch.observer/filing/0000950170-23-067790.json
- Plain text: https://secwatch.observer/filing/0000950170-23-067790.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.